Why the rise of generics could mean a new game plan for the industry; plus Nycomed's leap into the big time.
Executive Interviews
Starting at phase zero
Michael Butler of Xceleron looks at the value a microdose study adds to a drug development programme.
The future of biomarker assays
Ralph McDade of Rules Based Medicine explains why more is better when it comes to data used to identify meaningful biomaker patterns.
Medical communications in a changing world
Amanda Smith of Caudex Medical explains the effects of the movement towards evidence-based medicine.
Moving ahead in medical communications
David Swinbanks tells NGP about Nature Publishing Group’s recent move into medical communications with its new division, Macmillan Medical Communications.
Tools for screening and validation
Taqman SNP Genotyping Assays, developed by Applied Biosystems, are a state-of-the-art technology for screening and validation of polymorphisms. Recently Applied Biosystems introduced two new products to complement this offering; the high throughput Taqman Open Array Genotyping System and Taqman Copy Number Assays.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.